Nissan Chemical Corporation (4021.T) Bundle
Who's piling into Nissan Chemical Corporation (4021.T) and why? With institutional investors holding roughly 70% of shares and the top 12 shareholders owning 51%, ownership is strikingly concentrated-led by The Master Trust Bank of Japan at 23.7% and Nomura Asset Management with a 10.03% stake (13,525,600 shares as of March 31, 2025), while global names like BlackRock hold 5.11% (6,892,696 shares as of March 14, 2025); these positions sit alongside a market capitalization of 729.16 billion yen (Dec 12, 2025), an ROE of 18.45% (Mar 31, 2025), a low beta of 0.19, trailing and forward P/Es of 16.24 and 15.01 (Dec 12, 2025), and an annual dividend of 180 yen per share (ex-dividend Mar 30, 2026)-all factors that help explain why strategic institutional players control the narrative and why the stock's price may react sharply to their trades; read on to unpack who these investors are, how their stakes were built, and what it means for shareholder value
Nissan Chemical Corporation (4021.T) - Who Invests in Nissan Chemical Corporation (4021.T) and Why?
Nissan Chemical Corporation (4021.T) exhibits a concentrated, institution-heavy shareholder base that shapes both governance dynamics and market sensitivity. Institutional investors hold approximately 70% of shares, reflecting confidence in the company's financial stability, R&D pipeline, and exposure to specialty chemicals and life-science businesses.- Institutional ownership: ~70% of outstanding shares - a sign of sustained institutional conviction.
- Top 12 shareholders: collectively own ~51% - concentrated ownership with potential influence on corporate strategy and board composition.
- Largest single shareholder: Nomura Asset Management Co., Ltd. - 10.03% stake.
- Major global allocator: BlackRock, Inc. - 5.11% stake, consistent with diversified equity allocations.
- Domestic financial investor: Mizuho Financial Group, Inc. (asset management arm) - 4.7% stake.
- Implication: High institutional weighting increases sensitivity to large trades and repositioning, potentially amplifying short-term volatility.
| Shareholder | Stake (%) | Investor Type |
|---|---|---|
| Nomura Asset Management Co., Ltd. | 10.03 | Asset manager (domestic) |
| BlackRock, Inc. | 5.11 | Asset manager (global) |
| Mizuho Financial Group, Inc. (Asset Mgmt arm) | 4.70 | Bank/asset manager (domestic) |
| Other top institutional holders (combined) | ~31.16 | Mutual funds, pensions, insurers, asset managers |
| Top 12 shareholders (total) | 51.00 | Mix of domestic & international institutions |
| Institutional ownership (total) | ~70.00 | Institutions |
- Exposure to specialty chemicals and pharmaceuticals with defensive/innovation-driven revenue streams.
- Stable cash flow potential and dividend policy appealing to income-oriented institutional mandates.
- Strategic long-term value from proprietary technologies and global customer relationships.
- Portfolio diversification benefits for large global managers like BlackRock seeking non-U.S. chemical sector exposure.
Nissan Chemical Corporation (4021.T) - Institutional Ownership and Major Shareholders of Nissan Chemical Corporation (4021.T)
Nissan Chemical's shareholder base is dominated by large institutional trustees and asset managers, reflecting concentrated ownership among Japanese trust banks and global asset managers. The largest holdings combine strategic corporate trust positions with long-term institutional investors, which influences governance, dividend expectations, and capital allocation.
- Major domestic trust banks and trust accounts hold the largest single-block positions, typically reflecting employee pension, trust, and cross-shareholding structures.
- Global asset managers appear as significant non-domestic holders, indicating international investor interest in specialty chemicals and advanced materials exposure.
- Top-ten concentration demonstrates a high level of ownership concentration - institutional stability but also potential for coordinated voting influence.
| Shareholder | Shares Held | % of Shares Outstanding | Reporting Date |
|---|---|---|---|
| Nomura Asset Management Co., Ltd. | 13,525,600 | 10.03% | March 31, 2025 |
| BlackRock, Inc. | 6,892,696 | 5.11% | March 14, 2025 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 32,860,000 | 23.7% | October 29, 2024 |
| Custody Bank of Japan, Ltd. (Trust Account) | 14,293,000 | 10.3% | October 29, 2024 |
| Custody Bank of Japan, Ltd. as Trustee for Mizuho Bank Retirement Benefit Trust Account Re-entrusted by Mizuho Trust and Banking Co., Ltd. | 5,767,000 | 4.2% | October 29, 2024 |
| Top 10 Major Shareholders (collective) | 77,192,000 | 55.1% | October 29, 2024 |
Why these institutions hold Nissan Chemical:
- Long-term investment in specialty chemicals and advanced materials with stable cash flows and R&D-driven growth potential.
- Pension and trust accounts use large equity positions for diversification and stable dividend yield exposure.
- Global managers like BlackRock seek exposure to Japan's corporate reform and potential upside from structural growth in electronics, agrochemicals, and life-science materials.
- High top-ten concentration aligns with Japan's cross-shareholding tradition and custody structures, reducing free float and volatility.
For company mission, vision, and broader strategic context see: Mission Statement, Vision, & Core Values (2026) of Nissan Chemical Corporation.
Nissan Chemical Corporation (4021.T) - Key Investors and Their Impact on Nissan Chemical Corporation (4021.T)
Nissan Chemical's shareholder base is notably concentrated among a mix of trust banks and global asset managers. Large institutional stakes create a governance dynamic where a handful of investors can materially influence board composition, capital allocation, dividend policy, and strategic M&A or R&D priorities. The most prominent holdings as reported in public filings point to sustained strategic interest from domestic trust accounts and increasing endorsement from major global asset managers.- Nomura Asset Management Co., Ltd. - 10.03% (as of 2025-03-31): a material active manager position that grants Nomura leverage in engagement on strategy, voting on governance matters and potentially in proposing shareholder resolutions.
- BlackRock, Inc. - 5.11% (as of 2025-03-14): a large passive/active global investor whose ownership signals confidence in long-term growth and often brings stewardship expectations on ESG and capital efficiency.
- The Master Trust Bank of Japan, Ltd. (Trust Account) - 23.7% (as of 2024-10-29): the largest single trust account holder, representing pooled pension and institutional holdings with substantial sway over corporate policy through concentrated voting power.
- Custody Bank of Japan, Ltd. (Trust Account) - 10.3% (as of 2024-10-29): another major trustee holding that contributes to concentrated institutional ownership and stability of share register.
- Custody Bank of Japan, Ltd. as Trustee for Mizuho Bank Retirement Benefit Trust Account Re-entrusted by Mizuho Trust and Banking Co., Ltd. - 4.2% (as of 2024-10-29): reflects retirement fund allocations and long-term investor orientation.
| Investor | Reported Stake | Reporting Date | Investor Type | Potential Influence |
|---|---|---|---|---|
| Nomura Asset Management Co., Ltd. | 10.03% | 2025-03-31 | Asset Manager | Active engagement, voting power on strategy and governance |
| BlackRock, Inc. | 5.11% | 2025-03-14 | Global Asset Manager | Long-term endorsement, ESG and stewardship pressure |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 23.7% | 2024-10-29 | Trust Bank (Pooled) | Major voting block; shapes corporate policy and board elections |
| Custody Bank of Japan, Ltd. (Trust Account) | 10.3% | 2024-10-29 | Trust Bank | Concentrated institutional ownership supporting stability |
| Custody Bank of Japan, Ltd. as Trustee for Mizuho Bank Retirement Benefit Trust Account | 4.2% | 2024-10-29 | Trustee / Retirement Fund | Long-horizon investor; influence via pension allocations |
- Combined stake of these named investors (approximate, based on reported figures): 53.34%, indicating majority of shares are held by the listed institutional investors and trust accounts.
- High concentration increases the probability of coordinated voting outcomes on director elections, capital allocation (dividends, buybacks), and large strategic initiatives such as M&A or major R&D investments.
- Trust-account dominance (Master Trust Bank + Custody Bank trust accounts) implies significant proxy voting driven by pension fund mandates and fiduciary stability rather than short-term trading.
- Strategic continuity: large trust holdings favor steady, long-term strategies (e.g., sustained R&D in specialty chemicals, agrochemicals, and pharma-related segments).
- Governance scrutiny: global managers like BlackRock bring expectations on ESG disclosures, board independence, and shareholder returns-pressures that can accelerate governance reforms or reporting improvements.
- Capital allocation discipline: concentrated institutional ownership can enable or constrain management proposals - e.g., approving sizable capital expenditures or large dividends/buybacks depending on alignment with investor priorities.
Nissan Chemical Corporation (4021.T) - Market Impact and Investor Sentiment
Nissan Chemical Corporation (4021.T) presents a profile that attracts a mix of income-seeking, quality, and risk-averse investors. Recent metrics highlight why market participants position themselves in the stock and how sentiment shapes market impact.- Market capitalization: 729.16 billion yen (as of December 12, 2025) - signals sizeable scale and investor confidence in financial stability.
- Return on equity (ROE): 18.45% (as of March 31, 2025) - denotes efficient profit generation on shareholder capital.
- Beta: 0.19 - indicates low volatility relative to the market, appealing to conservative portfolios and institutions seeking defensive exposure.
- Valuation: Trailing P/E 16.24; Forward P/E 15.01 (as of December 12, 2025) - suggests reasonable earnings multiple with modest expected earnings growth priced in.
- Dividend policy: Annual dividend 180 yen per share; ex-dividend date March 30, 2026 - supports income-oriented demand.
| Metric | Value | Date / Period |
|---|---|---|
| Market Capitalization | 729.16 billion yen | Dec 12, 2025 |
| Return on Equity (ROE) | 18.45% | FY ended Mar 31, 2025 |
| Beta | 0.19 | Trailing |
| Trailing P/E | 16.24 | Dec 12, 2025 |
| Forward P/E | 15.01 | Dec 12, 2025 (analyst consensus) |
| Annual Dividend | 180 yen / share | Ex-dividend Mar 30, 2026 |
- Income: Stable dividend with clear ex-dividend scheduling fuels demand from yield-focused retail and institutional investors.
- Quality growth: High ROE attracts growth-at-a-reasonable-price investors who value capital-efficient businesses.
- Low volatility: Beta of 0.19 appeals to asset allocators seeking defensive holdings or to pair with higher-beta exposures.
- Valuation appeal: Mid-teens P/E metrics balance reasonable entry multiples with anticipated earnings improvements.
- Analyst coverage & ownership: Positive or cautious analyst forecasts and visible institutional ownership levels influence liquidity and price discovery.
- Earnings beats/misses versus the forward P/E expectations.
- Dividend announcements and payout sustainability tied to cash flow trends.
- Changes in institutional holdings or activist interest that alter supply-demand balance.
- Sector-specific developments in specialty chemicals, agrichemicals, or materials that affect revenue mix and margin outlook.

Nissan Chemical Corporation (4021.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.